InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Palmer Ashleigh, Chairman & CEO. Director active across 1 companies, notably Provention Bio, Inc.. Cumulatively, 2 reports have been published. Total volume traded: €44k. The latest transaction was disclosed on 30 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€22,1283,750 shares@ €5.9008100.0% of flow
Common Stock
SEC:0001493152-21-030245·
Ideal exit: 27 Aug 2022 (T+270)
€22,1283,750 shares@ €5.900850.0% of flow
Common Stock
SEC:0001493152-21-030245:0·
Ideal exit: 27 Aug 2022 (T+270)
2 of 2 declarations
About Palmer Ashleigh
Ashleigh Palmer is the Director and CEO of Provention Bio, Inc. She leads the company by defining its strategic vision and overseeing its operations. Her expertise in the biopharmaceutical field enables her to guide Provention Bio towards cutting-edge innovations and therapeutic solutions.
